CAS 1991986-30-1

ML364

CAS : 1991986-30-1

Formule : C₂₄H₁₈F₃N₃O₃S₂

Degré de pureté : 98%

Couleur et forme : Solid

Masse moléculaire : 517.5432

Ref: IN-DA00AS5B

ML364

CAS : 1991986-30-1

ML364

Formule : C₂₄H₁₈F₃N₃O₃S₂

Degré de pureté : ≥98%

Masse moléculaire : 517.54

Ref: 54-BUP10817

ML364

CAS : 1991986-30-1

ML364 is an inhibitor of ubiquitin specific peptidase 2 (USP2) and can be used for the research of breast cancer.

Formule : C₂₄H₁₈F₃N₃O₃S₂

Degré de pureté : 99.35% - >99.99%

Couleur et forme : Solid

Masse moléculaire : 517.54

Ref: TM-T3555

ML364

CAS : 1991986-30-1

2-((4-Methylphenyl)sulfonamido)-N-(4-phenylthiazol-2-yl)-4-(trifluoromethyl)benzamide

Formule : C₂₄H₁₈F₃N₃O₃S₂

Degré de pureté : 99%

Masse moléculaire : 517.54

Ref: IN-DG764554

ML 364

CAS : 1991986-30-1

ML 364 is a small molecule that has been shown to inhibit epidermal growth factor receptor (EGFR) and β-catenin, which are proteins involved in cancer progression. It also inhibits the production of fatty acids and natriuretic peptides. ML 364 targets the EGFR pathway by inhibiting the binding of epidermal growth factor (EGF) to its receptors, thereby blocking cell proliferation and tumorigenesis. This molecule also blocks the activation of β-catenin, which is required for tumor development. In addition, it has been shown to have potential as a biomarker for cancer diagnosis and prognosis. The biochemical properties of ML 364 have been studied extensively in both animal models and human cells.

Formule : C₂₄H₁₈F₃N₃O₃S₂

Degré de pureté : Min. 95%

Masse moléculaire : 517.55 g/mol

Ref: 3D-FM172810